Latest News about Duchenne Muscular Dystrophy
Recent news which mentions Duchenne Muscular Dystrophy
Stealth BioTherapeutics Showcases New Nonclinical Data From Duchenne Muscular Dystrophy Program
March 17, 2022
Tickers
MITO
From Benzinga
Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death
December 21, 2021
Tickers
PFE
From Benzinga
From Benzinga
Dyne Therapeutics Highlights New Preclinical Data For Duchenne Muscular Dystrophy Program
October 01, 2021
Tickers
DYN
From Benzinga
Capricor Stock Is Moving Higher As Duchenne Dystrophy Cell Therapy Slows Disease Progression By 71%
September 24, 2021
Tickers
CAPR
From Benzinga
Solid Biosciences Stock Gains After Duchenne Dystrophy Gene Therapy Data
September 23, 2021
Tickers
SLDB
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>